Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2026 Jul 17;16:1722374. doi: 10.3389/fonc.2026.1722374

Deep learning-based super-resolution dynamic contrast-enhanced radiomics model for predicting NSMP endometrial cancer

Tingting Cui 1, Jie Ren 1, Bei Gu 2, Yongzhao Qin 1, Yunlong Yue 1,*
PMCID: PMC13423732  PMID: 42539566

Abstract

Objectives

To determine the performance of a deep learning-based super-resolution (SR) dynamic contrast-enhanced (DCE) radiomic model in predicting nonspecific molecular profile (NSMP) endometrial cancer (EC).

Methods

This study included 140 surgically confirmed EC patients (76 NSMP-type EC patients and 64 non-NSMP-type EC patients) who were randomly divided into training and testing cohorts. Deep learning-based SR reconstruction techniques were applied to convert original-resolution (OR) DCE images into SR images. Radiomic features were extracted from both the SR and OR images. Logistic regression (LR), support vector machine (SVM), and multilayer perceptron (MLP) algorithms were used to develop SR-DCE and OR-DCE models, respectively. Model performance was evaluated via area under the curve (AUC) analysis and decision curve analysis (DCA) methods.

Results

Among the three algorithms (LR, SVM, and MLP), the diagnostic effectiveness of the SR-DCE model was superior to that of the OR-DCE model (P < 0.05). In the testing set, the AUC values for the SR-DCE model were 0.841 (95% confidence interval (CI): 0.724–0.959), 0.800 (95% CI: 0.664–0.937) and 0.764 (95% CI: 0.618–0.911), whereas those for the OR-DCE model were 0.637 (95% CI: 0.464–0.810), 0.603 (95% CI: 0.422–0.785) and 0.656 (95% CI: 0.495–0.818), respectively. Specifically, for the SR-DCE model, both the LR and SVM algorithms exhibited significantly higher AUC values in the testing set than the MLP algorithm did (LR vs. MLP, P = 0.012; SVM vs. MLP, P = 0.041). The clinical utility of the three algorithms was favorable for the SR-DCE model.

Conclusions

Deep learning-based SR reconstruction technology can increase the diagnostic effectiveness of the DCE radiomics model for NSMP EC, and it could become a noninvasive preoperative predictive tool for NSMP EC.

Keywords: dynamic contrast-enhanced, endometrial carcinoma, magnetic resonance imaging, molecular classification, radiomic

1. Introduction

Endometrial cancer (EC) is a common type of malignant gynecological tumor that significantly affects women’s reproductive function and quality of life (1). As the demand for precise and individualized diagnosis and treatment of EC has increased, the molecular classification of this disease has gradually received attention. Clinical trial results have shown that patients with different molecular classifications of EC benefit from adjuvant therapy to varying degrees (2). In 2022, the European Society for Medical Oncology (ESMO) published Clinical Practice Guidelines stating that molecular classification should be incorporated into risk stratification to guide individualized treatment for patients (3). In accordance with the 2020 edition of the World Health Organization (WHO) classification of gynecological tumors, EC is classified into four molecular subtypes: POLE mutation (POLE mut), mismatch repair deficient (MMRd), nonspecific molecular profile (NSMP), and p53 abnormality (p53 abn) (4). In particular, NSMP EC is the most common subtype, accounting for 39% to 67% of all EC cases, and this subtype is mostly of a low grade and detected at the early stage, with a moderate prognosis (5–7). However, conventional molecular classification detection methods (such as next-generation sequencing) are costly and time consuming, and the confirmation of molecular classification on the basis of endometrial biopsies is challenging because of the high heterogeneity in tumors. Therefore, a cost-effective and noninvasive method for predicting NSMP EC is crucial for guiding the preoperative treatment of patients.

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can be used to clearly visualize subendometrial enhancement (corresponding to the junctional zone), making it a useful tool for the preoperative assessment of EC, such as myometrial invasion (8–10). However, the spatial resolution of DCE-MRI is insufficient, which may not be conducive to providing more internal information about the tumor. With the development of deep learning technology, super-resolution (SR) reconstruction (a technique that is based on a generative adversarial network) has been demonstrated to enhance the spatial resolution and image quality of medical images (11–13). Moreover, many studies have shown that radiomics based on SR reconstruction can increase the diagnostic and predictive effectiveness of the model (14, 15). However, whether the DCE-MRI radiomics model based on SR reconstruction can increase the efficiency of predicting NSMP EC is unknown.

Therefore, the purpose of this study was to enhance the spatial resolution of DCE-MRI images via SR reconstruction and to establish multiple radiomic models to verify their predictive value for NSMP EC.

2. Materials and methods

2.1. Study population

This retrospective study was approved by the institutional ethics committee (number: II T 2025-032-001), who waived the need for informed consent. The data included in this study were sourced from patients with EC who underwent pelvic MRI examination and subsequent surgical treatment at our hospital between January 2020 and March 2025. The inclusion and exclusion criteria for patients are shown in Figure 1. Finally, 140 patients (76 with NSMP EC and 64 with other types) were included and randomly divided into training and testing cohorts at a ratio of 7:3. Clinicopathological data, including age, tumor grade, myometrial infiltration, lymphovascular space invasion (LVSI), lymph node status and FIGO stage, were collected in baseline form. In this study, tumor staging was based on the 2009 FIGO criteria.

Figure 1.

Flowchart illustrating retrospective selection of 216 patients with EC who had pelvic MRI and surgery; 76 excluded for specified criteria, resulting in 140 patients split into NSMP EC (76) and other EC types (64).

Flowchart of patient recruitment.

2.2. Original DCE-MRI protocol and SR image reconstruction

All pelvic MRI examinations were performed using a 1.5-T MRI scanner (Ingenia, Philips Healthcare, The Netherlands). The original resolution (OR) DCE image acquisition time was 3 min 16 s, and twenty-five dynamic scans were collected with a temporal resolution of 7.8 s. The injection of 0.2 mmol/kg intravenous contrast agent (gadopentetate dimeglumine, CONSUN)) was carried out using a high-pressure syringe. Scanning was performed in the sagittal position, and the detailed acquisition parameters were as follows: repetition time=5.8 ms, echo time=1.73 ms, matrix=188×188, FOV = 300×300 mm2, and slice thickness=2.5 mm.

In this study, deep learning-based SR reconstruction technology was employed to increase the spatial resolution of DCE images. This technology relies on the original information contained in the images in combination with deep learning algorithms (with a generative adversarial network as the basic architecture) to convert low-resolution images into high-resolution ones, thereby improving the quality of the image. Multiple studies have confirmed that this technology provides excellent stability and reliability and has been widely applied in the field of MRI (16–18). The SR-DCE images in this study were obtained through the Onekey platform (version 3.2; China), and the spatial resolution of these new images was increased fourfold (that is, a pixel volume of 4 × 4 × 4 mm was transformed into 4 × 4 × 1 mm). The newly reconstructed images were named SR-DCE (Figure 2).

Figure 2.

Side-by-side comparison of two grayscale medical images labeled A and B, with A showing a lower-resolution scan and B displaying a clearer, super-resolution scan, highlighted by an arrow and triangle indicating structures.

Differences between the OR-DCE image (A) and the SR-DCE image (B). The SR-DCE image more clearly shows the enhancement of the tumor (indicated by the triangle) and the tumor–myometrium interface (indicated by the arrow).

2.3. Image segmentation and radiomic feature extraction

Early DCE images (approximately from the 5th phase) were selected for image segmentation because of their clear visualization of subendometrial enhancement, which corresponds to the tumor contour (10). First, the selected images (including OR and SR images) were subjected to N4 bias field correction to reduce intensity variations caused by magnetic field heterogeneity. These images were subsequently standardized by resampling to 1 × 1 × 1 mm resolution. Tumor contour delineation was performed slice-by-slice by two radiologists (with 7 and 8 years of experience, respectively), who remained blinded to patient information, using ITK-SNAP software (version 4.0). Intra-class correlation coefficient (ICC) was calculated to evaluate the reliability of image segmentation, and radiomic features with ICC > 0.85 were retained.

Radiomic features, including first-order, shape, texture and wavelet features, were extracted separately from the segmented volumes of interest (VOIs) in both the OR and the SR images using PyRadiomics.

2.4. Feature selection and model construction

All the features were subjected to Z score standardization to achieve a normal distribution, and the entire feature selection process was conducted solely on the training set data to prevent data leakage from the testing set. First, a t test was applied to evaluate the correlation between features and molecular subtypes, retaining only those with statistically significant associations. Subsequently, Pearson correlation coefficients were calculated to assess inter-feature correlations, with features with coefficients exceeding 0.9 being randomly removed to reduce redundancy. Finally, the least absolute shrinkage and selection operator (LASSO) regression algorithm was used to obtain the optimal feature set. Three machine learning algorithms, namely, logistic regression (LR), support vector machine (SVM), and multilayer perceptron (MLP), were employed to construct radiomic models. To avoid overfitting, we optimized hyperparameters for the models via grid search combined with 5-fold cross-validation on the training set.

2.5. Statistical analysis

Continuous variables were described as the mean ± standard deviation (SD), while categorical variables were presented as frequencies and percentages. Differences between NSMP EC and other types were compared using Student’s t test, the Mann–Whitney U test, or the chi-square test. The diagnostic performance of each model was evaluated using receiver operating characteristic (ROC) curves, and the area under the curve (AUC), sensitivity, specificity, accuracy, precision, recall, and F1 score were calculated for both the training and testing sets. Comparisons of AUC values between models were performed using the DeLong test. Decision curve analysis (DCA) was employed to calculate the net benefit of the models across specific threshold ranges, thereby assessing their clinical utility. A P value < 0.05 was considered to indicate statistical significance. Data analysis was conducted using Python (version 3.7.12) and SPSS (version 26.0).

3. Results

3.1. Clinicopathological characteristics of the participants

The baseline clinicopathological characteristics of the EC patients are detailed in Table 1. The results revealed no statistically significant differences between the training and testing sets for any of the evaluated features, except pathological grade in the testing set.

Table 1.

The baseline clinicopathological characteristics of EC patients1.

Characteristic Training set Training set p Testing set Testing set p
NSMP non NSMP NSMP non NSMP
Age (years) 54.80 ± 11.34 57.29 ± 10.03 0.253 55.88 ± 14.15 61.31 ± 10.24 0.190
Myometrial invasion 0.287 0.477
 <50% 41 34 23 12
 ≥50% 9 14 3 4
Grade 0.240 <0.001
 G1 20 13 12 2
 G2 20 19 12 3
 G3 10 16 2 11
FIGO stage (2009) 0.294 0.234
 I 43 38 25 13
 II 4 2 0 0
 III 2 7 1 2
 IV 1 1 0 1
Lymph node status 0.243 0.271
 negative 48 42 26 14
 positive 2 6 0 2
LVSI 0.050 0.846
 negative 42 31 23 13
 positive 2 17 3 3

FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion.

3.2. DCE-MRI radiomic feature selection

A total of 234 first-order features, 14 shape features, and 949 texture features were extracted from early DCE images, and their distribution proportions are shown in Supplementary Figure S1. The t tests and correlation analysis results revealed 31 features in the OR-DCE group and 41 features in the SR-DCE group. The LASSO algorithm was subsequently employed for optimal feature selection, ultimately retaining 7 features for model development. The details of the least absolute shrinkage and selection operator (LASSO) method and the weight coefficients of the selected features are shown in Supplementary Figures S2 and S3, respectively.

3.3. Multiple model construction and evaluation

The final retained features were used in combination with the LR, SVM, and MLP algorithms for training and testing to develop predictive models. As shown in Figure 3 and Table 2, in the training set, the AUC values for the SR-DCE model across the three algorithms were 0.800 (95% confidence interval (CI): 0.713–0.887), 0.832 (95% CI: 0.753–0.912) and 0.801 (95% CI: 0.715–0.887), whereas those for the OR-DCE model were 0.792 (95% CI: 0.704–0.879), 0.739 (95% CI: 0.641–0.837) and 0.779 (95% CI: 0.688–0.871), respectively. In the testing set, the AUC values for the SR-DCE model were 0.841 (95% CI: 0.724–0.959), 0.800 (95% CI: 0.664–0.937) and 0.764 (95% CI: 0.618–0.911), whereas those for the OR-DCE model were 0.637 (95% CI: 0.464–0.810), 0.603 (95% CI: 0.422–0.785) and 0.656 (95% CI: 0.495–0.818), respectively. Notably, the AUC values of the SR-DCE model were significantly greater than those of the OR-DCE model across the three algorithms in the testing set (P < 0.05). Specifically, for the SR-DCE model, compared with the MLP algorithm, both the LR and the SVM algorithms resulted in significantly higher AUC values in the testing set (LR vs. MLP, P = 0.012; SVM vs. MLP, P = 0.041); the values of the LR and the SVM were comparable (P = 0.128). Within a defined threshold range, the clinical utility of the SR-DCE model was favorable across the three algorithms, as shown in Figure 4.

Figure 3.

Two side-by-side ROC curve graphs labeled A and B compare the performance of six machine learning models for predicting outcomes, with sensitivity plotted against one minus specificity. Each model is represented by a distinct color and line style. Legends identify each model by abbreviation and provide AUC values with ninety-five percent confidence intervals. Panel A shows higher AUCs for the SR group, while Panel B displays increased separation among models, with SR_LR and SR_SVM performing best. A diagonal dashed line indicates random performance in both panels.

The comparisons of AUC values for OR-DCE and SR-DCE model across the three algorithms. [(A) the training set; (B) the testing set]. Subfigures (A) shows that both models achieve high AUC values across the three algorithms in the training sets; subfigures (B) shows the AUC values of the SR-DCE model are higher than those of the OR-DCE model across the three algorithms in the testing set.

Table 2.

The diagnostic performance of radiomic models for predicting NSMP EC1.

Model Cohort Accuracy AUC 95%Cl Sensitivity Specificity PPV NPV Precision Recall F1 score
OR_LR Training 0.724 0.792 0.704-0.879 0.740 0.708 0.725 0.723 0.725 0.740 0.733
OR_SVM Training 0.704 0.739 0.641-0.837 0.760 0.646 0.691 0.721 0.691 0.760 0.724
OR_MLP Training 0.724 0.779 0.688-0.871 0.700 0.750 0.745 0.706 0.745 0.700 0.722
SR_LR Training 0.735 0.800 0.713-0.887 0.600 0.875 0.833 0.677 0.833 0.600 0.698
SR_SVM Training 0.755 0.832 0.753-0.912 0.720 0.792 0.783 0.731 0.783 0.720 0.750
SR_MLP Training 0.735 0.801 0.715-0.887 0.780 0.687 0.722 0.750 0.722 0.780 0.750
OR_LR Testing 0.667 0.637 0.464-0.810 0.654 0.687 0.773 0.550 0.773 0.654 0.708
OR_SVM Testing 0.643 0.603 0.422-0.785 0.577 0.750 0.789 0.522 0.789 0.577 0.667
OR_MLP Testing 0.619 0.656 0.495-0.818 0.462 0.875 0.857 0.500 0.857 0.462 0.600
SR_LR Testing 0.786 0.841 0.724-0.959 0.692 0.937 0.947 0.652 0.947 0.692 0.800
SR_SVM Testing 0.810 0.800 0.664-0.937 0.731 0.937 0.950 0.682 0.950 0.731 0.826
SR_MLP Testing 0.762 0.764 0.618-0.911 0.692 0.875 0.900 0.636 0.900 0.692 0.783

LR, logistic regression; SVM, support vector machine; MLP, multilayer perceptron; AUC, the area under curve; 95%CI: 95% confidence interval; PPV, positive predict value; NPV, negative predict value.

Figure 4.

Panel A and panel B display decision curve analysis line charts showing net benefit versus threshold probability for three models: SR_LR (blue), SR_SVM (orange), and SR_MLP (green). Each panel includes “Treat all” (black solid) and “Treat none” (black dotted) reference lines. Both charts illustrate model performance across a range of threshold probabilities, with net benefit decreasing as threshold increases. A legend in the upper right of each panel identifies each line.

Decision curve analysis for SR-DCE model across the three algorithms. [(A) the training set; (B) the testing set]. Subfigures (A, B) demonstrate that the SR-DCE model yields promising clinical value in both the training and testing sets.

4. Discussion

As the most common molecular subtype, accurate and noninvasive preoperative prediction of NSMP EC can provide evidence for clinicians to assess patient risk stratification, thereby sparing unnecessary lymphadenectomy, radiotherapy and chemotherapy. Although DCE-MRI is a crucial tool for the preoperative assessment of EC, its practical application often prioritizes temporal resolution at the expense of spatial resolution. This compromise may limit the extraction of additional radiomic features associated with tumor heterogeneity. Therefore, adopting deep learning-based SR technology to enhance the image spatial resolution and develop predictive models represents a promising direction for increasing the predictive performance for NSMP EC.

At present, SR reconstruction technology is used for the diagnosis and prognosis prediction of multiple-system lesions. Li C et al. (14) indicated that SR-based radiomic models demonstrate favorable feasibility and effectiveness in predicting uterine fibroid prognosis. Shiraishi K et al. (12) revealed the potential of SR deep learning reconstruction techniques to enhance prostate PI-RADS score assessment capabilities. In this study, we employed 3D deep learning-based SR reconstruction to convert low-resolution pelvic DCE images into SR images with a resolution increase of 4 times. Radiomic models were established using the LR, SVM, and MLP algorithms on the basis of OR-DCE and SR-DCE images to validate their clinical value in predicting NSMP EC. In both the training and testing sets, compared with the OR-DCE models, the SR-DCE models consistently exhibited higher AUC values across all the algorithms, demonstrating significant predictive potential for NSMP EC. These findings provide robust data support for noninvasive preoperative molecular subtyping of EC. For the SR-DCE model, the AUC values among the three algorithms were comparable in the training set. However, in the testing set, compared with the MLP (0.764), the LR and SVM achieved higher AUC values (0.841 and 0.800, respectively). In this study, these three algorithms were employed for model construction, primarily because of their ease of implementation and strong generalization capability and because they have been extensively adopted and validated in numerous prior studies (19–22). However, regarding NSMP EC prediction using the SR-DCE model, it is not obvious which algorithm has more advantages. In the testing set of this study, the diagnostic effectiveness of the LR and SVM algorithms is greater than that of the MLP algorithms, but the LR and SVM algorithms are comparable. This may require external data and a larger sample size to confirm the optimal algorithm.

Yue W et al. (23) employed 12 algorithms combined with multisequence MR images to predict the molecular subtypes of EC. Their results demonstrated that the LR algorithm exhibited superior diagnostic performance, achieving an AUC value of 0.71 for NSMP EC prediction, which was lower than that achieved in our study. In our research, the SR-DCE images exhibited greater clarity and provided a more distinct tumor–myometrium interface than the original images did, which was conducive to accurately delineating the volume of the tumor. In our study, the AUC value of the LR in the SR-DCE model of the testing set is 0.841, which is higher than the 0.639 in the OR-DCE model. Obviously, SR-DCE images provide more information on tumor heterogeneity beyond human visual perception, which may increase the predictive ability of the model. Distinct molecular subtypes of EC reflect varied tumor heterogeneity. The finally selected radiomic features in this study were mainly texture features. These features describe spatial patterns of images, uncover detailed structural information, quantify intratumoral textural distributions, and consequently mirror tumor heterogeneity. Conversely, Zhou J et al. (24) employed LR algorithms incorporating both intratumoral and peritumoral features to predict the molecular subtypes of EC, achieving an impressive AUC value of 0.943 for NSMP EC in their testing set. The superior diagnostic performance of their model suggests the potential clinical utility of peritumoral features in improving prediction accuracy. Future investigations will aim to explore whether SR-derived peritumoral features can further enhance the ability to predict NSMP EC.

Limitations of this study include the following: First, it is a single-center study with a small sample size, and the lack of external/multicenter validation inevitably limits the generalizability of our model. In future work, we plan to collect multicenter data to further validate the performance and robustness of the proposed model. Second, as a retrospective study, potential selection biases may exist. Third, this study did not incorporate peritumoral radiomic features. We will consider integrating multi-regional radiomic features from both intratumoral and peritumoral regions to further improve the predictive performance of the models. Finally, the adoption of SR technology increased the workload of manual image segmentation. Future research could explore automatic segmentation techniques to increase efficiency and reproducibility.

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Yoichi Watanabe, University of Minnesota Twin Cities, United States

Reviewed by: Ning Ma, Capital Medical University, China

Guowen Liu, National Center for Children’s Health, China

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Author contributions

TC: Writing – review & editing, Conceptualization, Writing – original draft. JR: Software, Formal analysis, Writing – review & editing, Data curation. BG: Supervision, Writing – review & editing. YQ: Data curation, Writing – review & editing. YY: Writing – review & editing, Supervision, Conceptualization, Validation.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2026.1722374/full#supplementary-material

Presentation1.pptx (684.3KB, pptx)

References

  • 1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer J For Clin. (2024) 74:12–49. doi:  10.3322/caac.21820 [DOI] [PubMed] [Google Scholar]
  • 2. León-Castillo A, de Boer SM, Powell ME, Mileshkin LR, Mackay HJ, Leary A, et al. Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on prognosis and benefit from adjuvant therapy. J Clin Oncol Off J Am Soc Clin Oncol. (2020) 38:3388–97. doi:  10.1200/jco.20.00549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Oaknin A, Bosse TJ, Creutzberg CL, Giornelli G, Harter P, Joly F, et al. Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc For Med Oncol. (2022) 33:860–77. doi:  10.1016/j.annonc.2022.05.009 [DOI] [PubMed] [Google Scholar]
  • 4. McCluggage WG, Singh N, Gilks CB. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology. (2022) 80:762–78. doi:  10.1111/his.14609 [DOI] [PubMed] [Google Scholar]
  • 5. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated genomic characterization of endometrial carcinoma. Nature. (2013) 497:67–73. doi:  10.1038/nature12113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Kang N, Zhang X, Wang Z, Dai Y, Lu S, Su W, et al. Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population. Pathol Res Pract. (2024) 254:155152. doi:  10.1016/j.prp.2024.155152 [DOI] [PubMed] [Google Scholar]
  • 7. Chacon E, Boria F, Lyer RR, Fanfani F, Malzoni M, Bretová P, et al. SENECA study: Staging endometrial cancer based on molecular classification. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc. (2024) 34:1313–21. doi:  10.1136/ijgc-2023-esgo.889 [DOI] [PubMed] [Google Scholar]
  • 8. Fujii S, Kido A, Baba T, Fujimoto K, Daido S, Matsumura N, et al. Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging. Eur J Radiol. (2015) 84:581–9. doi:  10.1016/j.ejrad.2015.01.004 [DOI] [PubMed] [Google Scholar]
  • 9. Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Archiv: Int J Pathol. (2021) 478:153–90. doi:  10.1136/ijgc-2020-002230 [DOI] [PubMed] [Google Scholar]
  • 10. Cui T, Shi F, Gu B, Jin Y, Guo J, Zhang C, et al. Peritumoral enhancement for the evaluation of myometrial invasion in low-risk endometrial carcinoma on dynamic contrast-enhanced MRI. Front Oncol. (2021) 11:793709. doi:  10.3389/fonc.2021.793709 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Yasaka K, Kanzawa J, Nakaya M, Kurokawa R, Tajima T, Akai H, et al. Super-resolution deep learning reconstruction for 3D brain MR imaging: Improvement of cranial nerve depiction and interobserver agreement in evaluations of neurovascular conflict. Acad Radiol. (2024) 31:5118–27. doi:  10.1016/j.acra.2024.06.010 [DOI] [PubMed] [Google Scholar]
  • 12. Shiraishi K, Nakaura T, Kobayashi N, Uetani H, Nagayama Y, Kidoh M, et al. Enhancing thin slice 3D T2-weighted prostate MRI with super-resolution deep learning reconstruction: Impact on image quality and PI-RADS assessment. Magn Reson Imaging. (2025) 117:110308. doi:  10.1016/j.mri.2024.110308 [DOI] [PubMed] [Google Scholar]
  • 13. Hokamura M, Nakaura T, Yoshida N, Uetani H, Shiraishi K, Kobayashi N, et al. Super-resolution deep learning reconstruction approach for enhanced visualization in lumbar spine MR bone imaging. Eur J Radiol. (2024) 178:111587. doi:  10.1016/j.ejrad.2024.111587 [DOI] [PubMed] [Google Scholar]
  • 14. Li C, He Z, Lv F, Liao H, Xiao Z. Predicting the prognosis of HIFU ablation of uterine fibroids using a deep learning-based 3D super-resolution DWI radiomics model: A multicenter study. Acad Radiol. (2024) 31:4996–5007. doi:  10.1016/j.acra.2024.06.027 [DOI] [PubMed] [Google Scholar]
  • 15. Wang L, Guo T, Wang L, Yang W, Wang J, Nie J, et al. Improving radiomic modeling for the identification of symptomatic carotid atherosclerotic plaques using deep learning-based 3D super-resolution CT angiography. Heliyon. (2024) 10:e29331. doi:  10.1016/j.heliyon.2024.e29331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Guerreiro J, Tomás P, Garcia N, Aidos H. Super-resolution of magnetic resonance images using generative adversarial networks. Computerized Med Imaging Graphics: Off J Computerized Med Imaging Soc. (2023) 108:102280. doi:  10.1016/j.compmedimag.2023.102280 [DOI] [PubMed] [Google Scholar]
  • 17. Qiu D, Cheng Y, Wang X. Medical image super-resolution reconstruction algorithms based on deep learning: A survey. Comput Methods Programs BioMed. (2023) 238:107590. doi:  10.1016/j.cmpb.2023.107590 [DOI] [PubMed] [Google Scholar]
  • 18. Matsuo K, Nakaura T, Morita K, Uetani H, Nagayama Y, Kidoh M, et al. Feasibility study of super-resolution deep learning-based reconstruction using k-space data in brain diffusion-weighted images. Neuroradiology. (2023) 65:1619–29. doi:  10.1007/s00234-023-03212-y [DOI] [PubMed] [Google Scholar]
  • 19. Huang S, Cai N, Pacheco PP, Narrandes S, Wang Y, Xu W. Applications of support vector machine (SVM) learning in cancer genomics. Cancer Genomics Proteomics. (2018) 15:41–51. doi:  10.21873/cgp.20063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Zhang Z, Wan X, Lei X, Wu Y, Zhang J, Ai Y, et al. Intra- and peri-tumoral MRI radiomics features for preoperative lymph node metastasis prediction in early-stage cervical cancer. Insights Into Imaging. (2023) 14:65. doi:  10.1186/s13244-023-01405-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Yan R, Qin S, Xu J, Zhao W, Xin P, Xing X, et al. A comparison of 2D and 3D magnetic resonance imaging-based intratumoral and peritumoral radiomics models for the prognostic prediction of endometrial cancer: A pilot study. Cancer Imaging: Off Publ Int Cancer Imaging Soc. (2024) 24:100. doi:  10.1186/s40644-024-00743-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Meng X, Yang D, Jin H, Xu H, Lu J, Liu Z, et al. MRI-based radiomics model for predicting endometrial cancer with high tumor mutation burden. Abdominal Radiol (New York). (2025) 50:1822–30. doi:  10.1007/s00261-024-04547-7 [DOI] [PubMed] [Google Scholar]
  • 23. Yue W, Han R, Wang H, Liang X, Zhang H, Li H, et al. Development and validation of clinical-radiomics deep learning model based on MRI for endometrial cancer molecular subtypes classification. Insights Into Imaging. (2025) 16:107. doi:  10.1186/s13244-025-01966-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Zhou J, Yu X, Cui Y, Zhou Q, Xu Q, Zhang X, et al. Prediction of molecular subtypes of endometrial cancer patients on the basis of intratumoral and peritumoral radiomic features from multiparametric MR images. Eur J Radiol. (2025) 187:112110. doi:  10.1016/j.ejrad.2025.112110 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Presentation1.pptx (684.3KB, pptx)

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES